Importantly, PSMA low/negative prostate carcinoma lesions have been shown to show strong enrichment of genes involved in cell proliferation, inflammatory response, hypoxia upregulation, amino acid transporters, and genes involved in glycolysis. The gene discussed is FOLH1; the disease is prostate carcinoma.